ORCA Therapeutics Competitors and Similar CompaniesClear all
ORCA Therapeutics's competitors and similar companies include HUYA Bioscience International, Deciphera Pharmaceuticals and PharmaEssentia.
 ORCA Therapeutics ORCA Therapeutics is a biopharmaceutical company designing and developing immunotherapies for the treatment of cancer using Oncolytic Replication Competent Agents (ORCA). |  HUYA Bioscience International HUYA Bioscience International is a company specializing in the biopharmaceutical products. |  Deciphera Pharmaceuticals Deciphera Pharmaceuticals is a clinical-stage biopharmaceutical company that develops medicines for patients with cancer. |  PharmaEssentia PharmaEssentia (藥華醫藥股份有限公司) is a biotech company focused on the areas of hematology, oncology, dermatology, and infectious diseases. | |
Founding Date | Founding Date 2005 | Founding Date 2004 | Founding Date 2003 | Founding Date 2003 |
Type | Type Private | Type Private | Type Public | Type Public |
Tags | ||||
Locations | Locations 's-Hertogenbosch, NL HQ Amsterdam, NL Nijmegen, NL | Locations San Diego, US HQ Chengdu Shi, CN Guangzhou Shi, CN Hangzhou, CN Shenzhen Shi, CN Shenzhen Shi, CN Suzhou Shi, CN see more | Locations Waltham, US HQ Lawrence, US | Locations Taipei, TW HQ Shinjuku City, JP Burlington, US |
Employees | Employees 6 | Employees 1113% increase | Employees 35037% increase | Employees 4897% increase |
Financial | ||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $163.4m (FY, 2023) | Revenue (est.) NT$15.6b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods $3.7m (FY, 2023) | Cost of goods NT$1.3b (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit $159.6m (FY, 2023) | Gross profit NT$14.4b (FY, 2025) |
Net income | Net income N/A | Net income N/A | Net income ($194.9m) (FY, 2023) | Net income NT$5b (FY, 2025) |
Funding | ||||
Latest funding round | Latest funding round $ 1.7m (about 10 years ago) | Latest funding round $ 7.6m (over 14 years ago) | Latest funding round N/A | Latest funding round N/A |
Total funding raised | Total funding raised $ 1.7m | Total funding raised $ 12.6m | Total funding raised $ 714m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
HUYA Bioscience International
HQ
San Diego, US
Employees
111↑ 3% increase
HUYA Bioscience International is a company specializing in the biopharmaceutical products.
View companyDeciphera Pharmaceuticals
HQ
Waltham, US
Employees
350↑ 37% increase
Deciphera Pharmaceuticals is a clinical-stage biopharmaceutical company that develops medicines for patients with cancer.
View companyPharmaEssentia
HQ
Taipei, TW
Employees
489↑ 7% increase
PharmaEssentia (藥華醫藥股份有限公司) is a biotech company focused on the areas of hematology, oncology, dermatology, and infectious diseases.
View company